Cargando…

The tumour suppressor Ras-association domain family protein 1A (RASSF1A) regulates TNF-α signalling in cardiomyocytes

AIMS: Tumour necrosis factor-α (TNF-α) plays a key role in the regulation of cardiac contractility. Although cardiomyocytes are known to express the TNF-α receptors (TNFRs), the mechanism of TNF-α signal transmission is incompletely understood. The aim of this study was to investigate whether the tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Tamer M.A., Zi, Min, Prehar, Sukhpal, Maqsood, Arfa, Abou-Leisa, Riham, Nguyen, Loan, Pfeifer, Gerd P., Cartwright, Elizabeth J., Neyses, Ludwig, Oceandy, Delvac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207857/ https://www.ncbi.nlm.nih.gov/pubmed/24776599 http://dx.doi.org/10.1093/cvr/cvu111

Ejemplares similares

The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy
por: Mohamed, Tamer M. A., et al.
Publicado: (2016)

The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice
por: Omede, Ameh, et al.
Publicado: (2016)

Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion
por: Stafford, Nicholas, et al.
Publicado: (2020)

PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia
por: Stafford, Nicholas, et al.
Publicado: (2021)

Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains
por: Zi, Min, et al.
Publicado: (2019)

The Cross-Talk Between the TNF-α and RASSF-Hippo Signalling Pathways
por: Oceandy, Delvac, et al.
Publicado: (2019)

Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS‐dependent mechanism
por: Lewis, Sophronia, et al.
Publicado: (2017)

Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU‐MP‐1, protects the heart against adverse effects during pressure overload
por: Triastuti, Efta, et al.
Publicado: (2019)

Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
por: Hegab, Zeinab, et al.
Publicado: (2017)

Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice
por: Nugroho, Ardiansah Bayu, et al.
Publicado: (2022)

Reduced expression of PMCA1 is associated with increased blood pressure with age which is preceded by remodelling of resistance arteries
por: Little, Robert, et al.
Publicado: (2017)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation
por: Li, Wenjiao, et al.
Publicado: (2018)

Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Bui, Thuy Anh, et al.
Publicado: (2023)

The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer
por: Harrell Stewart, Desmond R., et al.
Publicado: (2020)

Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction
por: Ulm, Susanne, et al.
Publicado: (2014)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

The Ras-association domain family (RASSF) members and their role in human tumourigenesis
por: van der Weyden, Louise, et al.
Publicado: (2007)

Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival
por: Robertson, Abigail, et al.
Publicado: (2017)

The SARAH Domain of RASSF1A and Its Tumor Suppressor Function
por: Dittfeld, Claudia, et al.
Publicado: (2012)

Metabolic Determinants of Cardiomyocyte Proliferation
por: Mohamed, Tamer M A, et al.
Publicado: (2022)

Induced Cardiomyocyte Proliferation: A Promising Approach to Cure Heart Failure
por: Salama, Abou Bakr M., et al.
Publicado: (2021)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation
por: Tian, Yihao, et al.
Publicado: (2011)

RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
por: García-Gutiérrez, Lucía, et al.
Publicado: (2020)

Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status
por: Cao, Dan, et al.
Publicado: (2013)

High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer
por: Kashuba, Vladimir I., et al.
Publicado: (2009)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

Calcium Extrusion Pump PMCA4: A New Player in Renal Calcium Handling?
por: van Loon, Ellen P. M., et al.
Publicado: (2016)

The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
por: Richter, A M, et al.
Publicado: (2012)

The Tumor Suppressor Gene, RASSF1A, Is Essential for Protection against Inflammation -Induced Injury
por: Gordon, Marilyn, et al.
Publicado: (2013)

MUC1-C REPRESSES THE RASSF1A TUMOR SUPPRESSOR IN HUMAN CARCINOMA CELLS
por: Rajabi, Hasan, et al.
Publicado: (2019)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma
por: Wang, Tao, et al.
Publicado: (2009)

Overexpression of RAS-Association Domain Family 6 (RASSF6) Inhibits Proliferation and Tumorigenesis in Hepatocellular Carcinoma Cells
por: Zhu, Nan, et al.
Publicado: (2017)

Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study
por: Maharani, Asri, et al.
Publicado: (2019)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_8o25dr58ig7nnh8s4b2haarkij